{"id":105672,"date":"2025-02-03T11:12:00","date_gmt":"2025-02-03T14:12:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/citeline-unveils-trialtrove-and-sitetrove\/"},"modified":"2025-02-03T11:12:00","modified_gmt":"2025-02-03T14:12:00","slug":"citeline-unveils-trialtrove-and-sitetrove","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/citeline-unveils-trialtrove-and-sitetrove\/","title":{"rendered":"Citeline Unveils Trialtrove+ and Sitetrove+"},"content":{"rendered":"<p><b>Citeline<\/b><\/p>\n<p align=\"left\">NEW YORK, Feb.  03, 2025  (GLOBE NEWSWIRE) &#8212; For over two decades, Citelines Trialtrove and Sitetrove have been trusted by clinical trial professionals worldwide to power smarter decisions with unparalleled data. Today, Citeline announces the launch of Trialtrove+ and Sitetrove+, with new features and enhancements that elevate use of its gold-standard data to a whole new level.<\/p>\n<p>The plus in Trialtrove+ and Sitetrove+ represents a broad set of new features designed to create additional efficiencies for clinical researchers, sponsors and planners, including:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\"><strong>Proprietary performance data<\/strong>: Trial, site and country performance metrics enable users to make data-backed decisions.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\"><strong>AI chatbot integration<\/strong>: Ella is an intuitive assistant that surfaces answers faster and with precision.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\"><strong>Enhanced usability<\/strong>: The intuitive interface transforms searches of Citelines robust database  leveraging over 60,000 data sources  into actionable insights.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\"><strong>Innovative tools<\/strong>: From a trial health calculator to site comparison capabilities and a KOL-focused Expert Finder, these solutions are built to answer clinical teams most pressing questions with unprecedented speed and accuracy.<\/li>\n<li><strong>Advanced analytics:<\/strong> Tracking of key trends coupled with intuitive insights enable users to benchmark and answer critical questions for accelerated decision-making.<\/li>\n<\/ul>\n<p>This game-changing innovation represents a shift from data discovery to true intelligence, unlocking the potential to save time and resources while improving trial success rates.<\/p>\n<p>Its a new era for Citeline, said Christina Masturzo, Vice President of Product at Citeline. This is the biggest leap forward in clinical trial planning weve ever delivered. With Trialtrove+ and Sitetrove+, were not just expanding our datasets; were transforming the way our clients approach trial planning by integrating deeper insights, smarter tools and a user experience that saves countless hours.<\/p>\n<p>In an increasingly competitive and complex clinical landscape, our clients need tools that do more than deliver data; they need solutions that empower them to act decisively and strategically, said Masturzo. Trialtrove+ and Sitetrove+ provide the clarity, confidence and control they need to navigate these challenges and succeed.<\/p>\n<p>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DKa9FYB1jcPikMr4xbYfK87WVPX4PLP7-8PJumNvDmCzl5b3pmgu714lQVspZQbbxianQKv_xvZ3X5xeR4Q7JnGrrYVjXAE02jN8QXY4P4o=\" rel=\"nofollow\" target=\"_blank\">Citeline.com\/plus<\/a>.<\/p>\n<p><strong>About Citeline<\/strong><\/p>\n<p>Citeline, a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jUyVKDylcgJ0gxgQBNVprJF2jP88riOd8U3PZw_B3GVQYi6IXRmC2CQSThfPxNbO8p6yq_XtZSROtGp0P5NNmg==\" rel=\"nofollow\" target=\"_blank\">Norstella<\/a> company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth.\u00a0<\/p>\n<p>Citelines global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&amp;D and approvals, market forecasts and more. For more information on one of the worlds most trusted health science partners, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DKa9FYB1jcPikMr4xbYfK77YruhJMUGTu5YxCpU4a44bDFNzYDVMQYEJBkmuu5bixaHLfcFrcQixw1-DuEeoCgEZtcgh_PSL3rslUVkj8wr13LQVXiInlzNTKmhkL592vrShEpTynR2bk5qECeUyU9fBcOpE1RbDRap2aDyqRgI=\" rel=\"nofollow\" target=\"_blank\">Citeline<\/a> and follow on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MxEuqNNuCrLUR6br5WkrNkgwLlWHKqvCLAyp9iOwUOMu-QkQC3XjFrEg75Z1viXRlwuC6owfbB6kRJkkTVBEg68EAUVr408ORbLWAXZMxF4=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9MfSDHMJeXyujrxh-7JJYjJEGqapLLxxedJgVq1hfJUuab343vwiPOAxN6qK1gEr\" rel=\"nofollow\" target=\"_blank\">X<\/a>.\u00a0<\/p>\n<p><strong>Citeline PR contact:<\/strong> <br \/>Diffusion PR for Citeline<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rpXNleDAO-DaMDSe8tEYY6lcqYbS6boXw5QklLZ-bPdmz8meINaEXHxsAI81NS0umQ1B35co71oWzFINi-rwQlKxZEnoZq7J-5PYR4jD05SFFF41ApH9KttG8BvgiPm7\" rel=\"nofollow\" target=\"_blank\">norstella@diffusionpr.com<\/a><br \/>213-318-4500<\/p>\n<p> <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM0OTA5NyM2NzA3NjA0IzIwMjkyMTI=\" \/> <br \/><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmJmZDM2MzUtMmRlZS00YzMwLTg2NWQtMjJhN2RhNDAxMzdlLTEwNDA3ODM=\/tiny\/Caerus-Us-1-Inc-dba-Citeline-.png\" \/><br \/>\n<a href=\"https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/5b2e0eec-7b0b-4eaf-970c-9a9be57274bc\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/5b2e0eec-7b0b-4eaf-970c-9a9be57274bc\/small\/citeline-logo-new-png.png\" border=\"0\" width=\"150\" height=\"29\" alt=\"Primary Logo\" \/><\/a><\/p>\n<p>A <b>OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da <b>OESP<\/b> e sao de inteira responsabilidade da <b>GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"NEW YORK, Feb.  03, 2025  (GLOBE NEWSWIRE) &#8212; For over two decades, Citelines Trialtrove and Sitetrove have been trusted by clinical trial professionals worl","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-105672","post","type-post","status-publish","format-standard","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/105672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=105672"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/105672\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=105672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=105672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=105672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}